ZNF569 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.780980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.147200E-01
Normal-vs-Stage2
6.527700E-02
Normal-vs-Stage3
2.978000E-02
Normal-vs-Stage4
3.933600E-01
Stage1-vs-Stage2
2.563400E-01
Stage1-vs-Stage3
1.258160E-01
Stage1-vs-Stage4
6.496200E-01
Stage2-vs-Stage3
3.704800E-01
Stage2-vs-Stage4
3.252800E-01
Stage3-vs-Stage4
6.101900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.933990E-01
Normal-vs-AfricanAmerican
3.186600E-01
Normal-vs-Asian
3.866300E-02
Caucasian-vs-AfricanAmerican
8.865800E-01
Caucasian-vs-Asian
3.061000E-01
AfricanAmerican-vs-Asian
3.728600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.872560E-01
Normal-vs-Female
1.785410E-01
Male-vs-Female
3.839400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.606600E-01
Normal-vs-Age(41-60Yrs)
2.854400E-01
Normal-vs-Age(61-80Yrs)
1.526570E-01
Normal-vs-Age(81-100Yrs)
1.134280E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.269180E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.505800E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.232800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.568200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.511800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.131440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.255300E-03
Normal-vs-Daily Drinker
7.897800E-02
Normal-vs-Weekly Drinker
1.266490E-02
Normal-vs-Occasional Drinker
2.921600E-01
Normal-vs-Social Drinker
5.756600E-01
Non Drinker-vs-Daily Drinker
8.403600E-01
Non Drinker-vs-Weekly Drinker
4.463600E-01
Non Drinker-vs-Occasional Drinker
2.318200E-01
Non Drinker-vs-Social Drinker
7.437900E-02
Daily Drinker-vs-Weekly Drinker
6.784800E-01
Daily Drinker-vs-Occasional Drinker
3.501200E-01
Daily Drinker-vs-Social Drinker
1.004250E-01
Weekly Drinker-vs-Occasional Drinker
4.857000E-01
Weekly Drinker-vs-Social Drinker
1.623230E-01
Occasional Drinker-vs-Social Drinker
4.739200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.703000E-01
Normal-vs-Grade 2
3.680600E-01
Normal-vs-Grade 3
4.444400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.120180E-01
Grade 1-vs-Grade 3
5.978100E-02
Grade 1-vs-Grade 4
3.703000E-01
Grade 2-vs-Grade 3
4.623800E-01
Grade 2-vs-Grade 4
3.680600E-01
Grade 3-vs-Grade 4
4.444400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.303600E-02
Normal-vs-NonDiabetic
1.666010E-01
Diabetic-vs-NonDiabetic
5.717800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.639100E-03
Normal-vs-NoPancreatitis
1.474440E-01
Pancreatitis-vs-NoPancreatitis
8.594100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.726000E-01
Normal-vs-N1
7.069500E-02
N0-vs-N1
2.808200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.484400E-02
Normal-vs-TP53-NonMutant
6.566400E-01
TP53-Mutant-vs-TP53-NonMutant
2.238600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
